Peptide reference
Semaglutide
Semaglutide is an FDA-approved GLP-1 receptor agonist. Compounded versions are a different thing with a different status.
Not yet attributed. This page has no named author or medical reviewer assigned. It must not publish in this state.
Educational only — not medical advice. Nothing here is a recommendation to take, obtain, or self-administer any compound. Talk to a qualified clinician.
At a glance
- FDA status
- FDA-approved
- Class
- GLP-1 agonist
- Evidence grade
- Strong
- Legal to sell as a supplement
- No
The Semaglutide reference is not published yet
- — No content file for this route.
The regulatory status above is maintained independently of the article and is current as of its stated review date.